SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-219952
Filing Date
2011-08-12
Accepted
2011-08-11 19:02:51
Documents
9
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 306293
2 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF JAMES M. FRINCKE dex311.htm EX-31.1 6623
3 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF ROBERT W. WEBER dex312.htm EX-31.2 6633
4 SECTION 1350 CERTIFICATIONS OF JAMES M. FRINCKE AND ROBERT W. WEBER dex321.htm EX-32.1 5808
  Complete submission text file 0001193125-11-219952.txt   1217034

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT hrbr-20110630.xml EX-101.INS 83162
6 XBRL TAXONOMY EXTENSION SCHEMA hrbr-20110630.xsd EX-101.SCH 8388
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrbr-20110630_cal.xml EX-101.CAL 34009
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrbr-20110630_lab.xml EX-101.LAB 105593
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrbr-20110630_pre.xml EX-101.PRE 67977
Mailing Address 9171 TOWNE CENTRE DRIVE SUITE 180 SAN DIEGO CA 92122
Business Address 9171 TOWNE CENTRE DRIVE SUITE 180 SAN DIEGO CA 92122 858-587-9333
Harbor BioSciences, Inc. (Filer) CIK: 0000899394 (see all company filings)

IRS No.: 133697002 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34584 | Film No.: 111028880
SIC: 2834 Pharmaceutical Preparations